FUL vs KWR: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: FUL is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. FUL and KWR share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined FUL and KWR exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

H.B. Fuller Company formulates and sells industrial adhesives, sealants and coatings from roughly 70 plants worldwide, with about 7,100 employees and trailing twelve-month revenue of ~$3.55 billion. The business runs in three segments. Hygiene, Health and Consumable Adhesives (~$422 million of revenue in the quarter ended May 30, 2026) glues diapers, tissue, food packaging, e-commerce cartons and medical devices. Engineering Adhesives (~$283 million) sells reactive, light-cure and two-part structural products into transportation, electronics, clean energy, aerospace, appliances and heavy machinery. Building Adhesive Solutions (~$245 million) covers commercial roofing, flooring, insulation, building envelope, caulks and sealants. The company has paid a quarterly dividend for 58 consecutive years and raised it for 33 straight.

Full FUL guide

Quaker Houghton, formed by the 2019 merger of Quaker Chemical and Houghton International, supplies process fluids and chemical management services used in making and shaping metal. Its products (metalworking fluids, hydraulic fluids, corrosion protection, cleaners, and surface treatments) are consumed on customer production lines in automotive, steel, aluminum, aerospace, and general industrial markets, and the company leans on formulation expertise, on-site technical service, and a razor-and-blade recurring-revenue model rather than commodity pricing. It generated roughly $1.98 billion in trailing revenue and carried a market capitalization of about $2.7 billion as of October 16, 2026, when the shares closed near $158.32 (legally the company is still Quaker Chemical Corporation).

Full KWR guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• FUL drivers: Margin expansion from pricing and Quantum Leap; Volume, which is where the story cracks.
• KWR drivers: Industrial demand recovery and volume growth; Margin expansion and the transformation program.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Leverage is the first constraint: total debt of ~$2.19 billion against ~$97 million of cash already sits near 3x trailing EBITDA of ~$610 million, and the new 7.625% notes carry a coupon well above the 4.000% notes they partly replace, so interest cost rises as the AMS deal closes. For KWR, kWR is cyclical, so a slowdown in automotive, steel, or broader industrial production would pressure both volumes and pricing.

Pick FUL if you believe its drivers more; KWR if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the FUL and KWR guides.

FUL. H.B. Fuller reports on a fiscal year ending in late November, so the latest print as of October 16, 2026 is the third quarter (ended August 29), released September 23 with a modest EPS beat. Fourth-quarter results are not expected until early 2027, so the next catalysts are the AMS closing and the board's answer to Ancora's raised bid. At ~10x forward earnings and ~8x EV/EBITDA, against a mean analyst target near $68, the gap between the margin story and the volume story remains wide.

KWR. Reported GAAP earnings have at times been distorted by non-cash impairment and intangible charges (2025 GAAP net income was slightly negative), so investors typically watch non-GAAP EPS and EBITDA instead. As of October 2026 the stock trades near 28x trailing GAAP earnings but about 17x analysts' 2027 EPS estimate of roughly $9.56, and the analyst consensus is a strong buy with a mean target near $193. The steadily rising dividend and recurring service revenue remain central to the valuation case.

Headline figures (approximate, October 2026): FUL shows revenue (ttm) ~$3.55B; Q3 FY2026 revenue ~$938M, up ~5.2% year over year, q3 fy2026 (quarter ended aug 29, 2026) Adjusted EPS $1.52 vs ~$1.46 consensus; net income ~$79M, margins (ttm) Gross ~32.7%, operating ~13.2%, net ~5.6%, net income / eps (ttm) ~$198M; trailing EPS ~$3.59, forward EPS estimate ~$5.18; KWR shows revenue (ttm) ~$1.98B (Q2 up ~10% YoY), market cap ~$2.7B, ebitda (ttm) ~$287M, q2 2026 adjusted eps $2.19 vs ~$1.66 estimate.

FUL and KWR are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined FUL and KWR exposure against your real portfolio. It is not an investment adviser.